Innovative medicines list: AIFA publishes December 2024 update

Asset Publisher

Innovative medicines list: AIFA publishes December 2024 update

AIFA updates the list of medicines that, in the opinion of the Scientific and Economic Committee for Medicines (CSE), meet the requirement of full or conditional therapeutic innovativeness.

At the same time, the evaluation reports for the recognition of innovativeness, for each therapeutic indication, are made available.

Published on: 13 January 2025

Asset Publisher

Site Map

Pricing and reimbursement

Share

Nested Applications

Highlights

23/04/2025 - AIFA’s top management on an institutional mission to London

15/04/2025 - AIFA-Regions working group: shared calculation method for the class economic impact of glyphozines

ALL NEWS

News

24/04/2025

Direct communication with healthcare professionals on Opzelura (ruxolitinib)

18/04/2025

Procedura di revisione e validazione degli elenchi delle indicazioni terapeutiche per fProcedure for the review and validation of lists of therapeutic indications for innovative medicines by pharmaceutical companiesarmaci innovativi da parte delle Aziende farmaceutiche

14/04/2025

AIFA updates the Transparency Lists

All news

Galleria

Nested Applications

Press

AIFA’s top management on an institutional mission to London

Aifa toggle bar Search

Aifa toggle bar Search